Can a med spa in Pennsylvania offer compounded semaglutide or tirzepatide?

Facility · part of The Practice Perimeter

⚠️ AND THE PROHIBITION IS THE WHOLE GLP-1 QUESTION IN ONE CLAUSE. “Pharmacists MAY NOT COMPOUND … DRUGS THAT ARE ESSENTIALLY COPIES OF A COMMERCIALLY AVAILABLE DRUG PRODUCT, except as provided in section 503a(b)(1)(D) of the Federal Food, Drug, and Cosmetic Act.” Where the branded GLP-1 can be obtained, a compounded version of it is an essential copy and Pennsylvania forbids compounding it — no quantity limit or supervision arrangement cures that.

49 Pa. Code § 27.602(2) · verified Sep 2, 2026 · regulatory monitoring, not legal advice

The rest of what Pennsylvania says on this

Every other rule we have verified under med-spa registration & licensing, each linked to its primary source.

  • PENNSYLVANIA ADOPTS THE FEDERAL COMPOUNDING REGIME AS ITS OWN, AND KEEPS IT CURRENT. “THE COMPOUNDING OF STERILE AND NONSTERILE PREPARATIONS SHALL BE DONE IN ACCORDANCE WITH SECTION 503a OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT … FEDERAL REGULATIONS PROMULGATED THEREUNDER, AND THE CURRENT VERSION OF THE USP CHAPTERS GOVERNING COMPOUNDING.” “Current version” means the standard moves without the rule being reissued.

    49 Pa. Code § 27.601 · verified Sep 2, 2026 · read at Cornell Legal Information Institute

  • The other two prohibitions bound the same rule. A pharmacist may not compound drugs “IDENTIFIED BY THE FDA AS WITHDRAWN OR REMOVED FROM THE MARKET BECAUSE THE DRUGS WERE FOUND TO BE UNSAFE OR INEFFECTIVE” under 21 CFR 216.24, unless used in an IRB-approved clinical trial; nor drugs the FDA has identified in the FDCA or the Code of Federal Regulations “AS PRODUCTS WHICH MAY NOT BE COMPOUNDED”. A Pennsylvania practice’s diligence question is therefore federal: what has the FDA said about this molecule.

    49 Pa. Code § 27.602(1), (3) · verified Sep 2, 2026 · read at Cornell Legal Information Institute

  • A CRNP must notify the Board in writing whenever a prescriptive authority collaborative agreement is updated or terminated, filing the change form and the amended agreement with the Board and paying the prescribed fee. An agreement that quietly lapses is a live compliance gap, not a paperwork one.

    49 Pa. Code §21.285 · verified Aug 17, 2026 · read at Cornell Legal Information Institute

  • A licensee may practice under a fictitious name only where that name is not misleading, deceptive, untrue or fraudulent, and where it is not otherwise prohibited by law — which is where a trading name that implies medical services the entity cannot lawfully provide would fail.

    49 Pa. Code §25.214(c) · verified Aug 17, 2026 · read at Cornell Legal Information Institute

  • 💰 PENNSYLVANIA’S COSMETOLOGY FEES ARE PUBLISHED AS A TWO-COLUMN TABLE — “EFFECTIVE NOVEMBER 5, 2022” and “EFFECTIVE JULY 1, 2024” — so the second figure in each row is the one now charged. On initial application the rows read “Esthetician $25 $26” and “Cosmetology salon or limited practice salon $135 $142”; on biennial renewal, “Esthetician $82 $97” and “Cosmetology salon or limited practice salon $129 $144”. Changing the salon is charged separately: “Change in cosmetology salon or limited practice salon (inspection required) $100 $105”.

    49 Pa. Code § 7.2(a), (b), (c) · verified Sep 2, 2026 · read at Cornell Legal Information Institute

How other states answer this

All 51 states side by side →

Related Pennsylvania questions

Every Pennsylvania question we can answer →

Get Pennsylvania changes as they publish

We scan the Pennsylvania legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.

Free · unsubscribe in one click · we never sell your address

← All Pennsylvania rules and changes · MedSpaRadar is regulatory monitoring and reference, not legal, medical, or compliance advice. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts. Legislative data via LegiScan (CC BY 4.0).